Mitochondrial dysfunction and oxidative stress in asthma: Implications for mitochondria-targeted antioxidant therapeutics

Pharmaceuticals

Volumn 4, Issue 3, 2011, Pages 429-456

  Hemachandra Reddy, P ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Asthma; Mitochondria targeted antioxidants; Mitochondrial dysfunction; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ASCORBIC ACID; BUTYLATED HYDROXYANISOLE; CHOLINE; CORTICOSTEROID; DEXAMETHASONE; MESSENGER RNA; MITOCHONDRIAL DNA; PEPTIDE DERIVATIVE; RESVERATROL; SS 31 PEPTIDE; THIOCTIC ACID; UBIDECARENONE; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; AGING; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ASTHMA; BRONCHUS HYPERREACTIVITY; CLINICAL TRIAL (TOPIC); CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG SAFETY; DRUG TARGETING; GENE DELETION; GENE EXPRESSION REGULATION; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; IMMUNITY; INFLAMMATION; MITOCHONDRIAL GENOME; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PNEUMONIA; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79955617984     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph4030429     Document Type: Review

References (127)

1. Busse, W.W.; Lemanske, R.F., Jr. Asthma. N. Engl. J. Med. 2001, 344, 350-362.
2. Lebowitz, M.D.; Barbee, R.; Burrows, B. Family concordance of IgE, atopy, and disease. J. Allergy Clin. Immunol. 1984, 73, 259-264.
3. Sarafino, E.P.; Goldfedder, J. Genetic factors in the presence, severity, and triggers of asthma. Arch. Dis. Child. 1995, 73, 112-116.
4. Zamel, N. In search of genes of asthma on the island of Tristan da Cunha. Can. Resp. J. 1995, 2, 18-22.
5. Heinzmann, A.; Deichmann, K.A. Genes for atopy and asthma. Curr. Opin. Allergy Clin. Immunol. 2001, 1, 387-392.
6. Van Eerdewegh, P.; Little, R.D.; Dupuis, J.; Del Mastro, R.G.; Falls, K.; Simon, J.; Torrey, D.; Pandit, S.; McKenny, J.; Braunschweiger, K., et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 2002, 418, 426-430.
7. Heinzmann, A.; Thoma, C.; Dietrich, H.; Deichmann, K.A. Identification of common polymorphisms in the mitochondrial genome. Allergy 2003, 58, 830-831.
8. Jones, M.; Mitchell, P.; Wang, J.J.; Sue, C. MELAS A3243G mitochondrial DNA mutation and age related maculopathy. Am. J. Ophthalmol. 2004, 138, 1051-1053.
9. Raby, B.A.; Klanderman, B.; Murphy, A.; Mazza, S.; Camargo, C.A., Jr.; Silverman, E.K.; Weiss, S.T. A common mitochondrial haplogroup is associated with elevated total serum IgE levels. J. Allergy Clin. Immunol. 2007, 120, 351-358.
10. Mabalirajan, U.; Dinda, A.K.; Kumar, S.; Roshan, R.; Gupta, P.; Sharma, S.K.; Ghosh, B. Mitochondrial structural changes and dysfunction are associated with experimental allergic asthma. J. Immunol. 2008, 181, 3540-3548.
11. Aguilera-Aguirre, L.; Bacsi, A.; Saavedra-Molina, A.; Kurosky, A.; Sur, S.; Boldogh, I. Mitochondrial dysfunction increases allergic airway inflammation. J. Immunol. 2009, 183, 5379-5387.
12. Holgate, S.T.; Davies, D.E.; Puddicombe, S.; Richter, A.; Lackie, P.; Lordan, J.; Howarth, P. Mechanisms of airway epithelial damage: epithelial-mesenchymal interactions in the pathogenesis of asthma. Eur. Respir. J. 2003, 22 (Suppl. 44), 24s-29s.
13. Steinke, J.W.; Borish, L. Th2 cytokines and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir. Res. 2001, 2, 66-70.
14. Fanta, C.H. Asthma. N. Engl. J. Med. 2009, 360, 1002-1014.
15. Martinez, F.D. Genes, environments, development and asthma: A reappraisal. Eur. Respir. J. 2007, 29, 179-184.
16. Eisner, M.D.; Yelin, E.H.; Katz, P.P.; Earnest, G.; Blanc, P.D. Exposure to indoorcombustion and adult asthma outcomes: environmental tobacco smoke, gas stoves, and woodsmoke. Thorax 2002, 57, 973-978.
17. Sarir, H.; Mortaz, E.; Karimi, K.; Kraneveld, A.D.; Rahman, I.; Caldenhoven, E.; Nijkamp, F.P.; Folkerts, G. Cigarette smoke regulates the expression of TLR4 and IL-8 production by human macrophages. J. Inflamm. (Lond) 2009, 6, 12.
18. Thomson, N.C.; Spears, M. The influence of smoking on the treatment response in patients with asthma. Curr. Opin. Allergy Clin. Immunol. 2005, 5, 57-63.
19. Ober, C.; Hoffjan, S.; Hoffjan, S. Asthma genetics 2006: The long and winding road to gene discovery. Genes Immun. 2006, 7, 95-100.
20. Bouzigon, E.; Corda, E.; Aschard, H.; Dizier, M.H.; Boland, A.; Bousquet, J.; Chateigner, N.; Gormand, F.; Just, J.; Le Moual, N.; Scheinmann, P.; Siroux, V.; Vervloet, D.; Zelenika, D.; Pin, I.; Kauffmann, F.; Lathrop, M.; Demenais, F. Effect of 17q21 variants and smoking exposure in early-onset asthma. N. Engl. J. Med. 2008, 359, 1985-1994.
21. Raby, B.A.; Van Steen, K.; Lasky-Su, J.; Tantisira, K.; Kaplan, F.; Weiss, S.T. Importin-13 genetic variation is associated with improved airway responsiveness in childhood asthma. Respir. Res. 2009, 10, 67.
22. Sharma, S.; Murphy, A.J.; Soto-Quiros, M.E.; Avila, L.; Klanderman, B.J.; Sylvia, J.S.; Celedón, J.C.; Raby, B.A.; Weiss, S.T. Association of VEGF polymorphisms with childhood asthma, lung function and airway responsiveness. Eur. Respir. J. 2009, 33, 1287-1294.
23. Hunninghake, G.M.; Cho, M.H.; Tesfaigzi, Y.; Soto-Quiros, M.E.; Avila, L.; Lasky-Su, J.; Stidley, C.; Melén, E.; Söderhäll, C.; Hallberg, J., et al. MMP12, lung function, and COPD in high-risk populations. N. Engl. J. Med. 2009, 361, 2599-2608.
24. Sharma, S.; Tantisira, K.; Carey, V.; Murphy A.J.; Lasky-Su, J.; Celedón, J.C.; Lazarus, R.; Klanderman, B.; Rogers, A.; Soto-Quirós, M., et al. A role for Wnt signaling genes in the pathogenesis of impaired lung function in asthma. Am. J. Respir. Crit. Care Med. 2010, 181, 328-336.
25. Verlaan, D.J.; Berlivet, S.; Hunninghake, G.M.; Madore, A.M.; Larivière, M.; Moussette, S.; Grundberg, E.; Kwan, T.; Ouimet, M.; Ge, B., et al. Allele-specific chromatin remodeling in the ZPBP2/GSDMB/ORMDL3 locus associated with the risk of asthma and autoimmune disease. Am. J. Hum. Genet. 2009, 85, 377-393.
26. Halapi, E.; Gudbjartsson, D.F.; Jonsdottir, G.M.; Bjornsdottir, U.S.; Bjornsdottir, U.S.; Thorleifsson, G.; Helgadottir, H.; Williams, C.; Koppelman, G.H.; Heinzmann, A., et al. A sequence variant on 17q21 is associated with age at onset and severity of asthma. Eur. J. Hum. Genet. 2010, 18, 902-908.
27. Cantero-Recasens, G.; Fandos, C.; Rubio-Moscardo, F.; Valverde, M.A.; Vicente, R. The asthma-associated ORMDL3 gene product regulates endoplasmic reticulum-mediated calcium signaling and cellular stress. Hum. Mol. Genet. 2010, 19, 111-121.
28. Himes, B.E.; Hunninghake, G.M.; Baurley, J.W.; Rafaels, N.M. /xnamexSleiman/x/namex, P.; Strachan, D.P.; Wilk, J.B.; Willis-Owen, S.A.; Klanderman, B.; Lasky-Su, J., et al. Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene. Am. J. Hum. Genet. 2009, 84, 581-593.
29. Murphy, A.; Tantisira, K.G.; Soto-Quirós, M.E.; Avila, L.; Klanderman, B.J.; Lake, S.; Weiss, S.T.; Celedón, J.C. PRKCA: a positional candidate gene for body mass index and asthma. Am. J. Hum. Genet. 2009, 85, 87-96.
30. Sharma, S.; Raby, B.A.; Hunninghake, G.M.; Soto-Quirós, M.; Avila, L.; Murphy, A.J.; Lasky-Su, J.; Klanderman, B.J.; Sylvia, J.S.; Weiss, S.T.; Celedón, J.C. Variants in TGFB1, dust mite exposure, and disease severity in children with asthma. Am. J. Respir. Crit. Care Med. 2009, 179, 356-362.
31. Hunninghake, G.M.; Soto-Quirós, M.E.; Lasky-Su, J.; Avila, L.; Ly, N.P.; Liang, C.; Klanderman, B.J.; Raby, B.A.; Gold, D.R.; Weiss, S.T.; Celedón, JC. Dust mite exposure modifies the effect of functional IL10 polymorphisms on allergy and asthma exacerbations. J. Allergy Clin. Immunol. 2008, 122, 93-98.
32. DeMeo, D.L.; Lange, C.; Silverman, E.K.; Sentern, J.M.; Drazen, J.M.; Barth, M.J.; Laird, N.; Weiss, S.T. Univariate and multivariate family-based association analysis of the IL-13 ARG130GLN polymorphism in the Childhood Asthma Management Program. Genet. Epidemiol. 2002, 23, 335-348.
33. Raby, B.A.; Soto-Quiros, M.E.; Avila, L.; Lake, S.L.; Murphy, A.; Liang, C.; Fournier, E.; Spesny, M.; Sylvia, J.S.; Verner, A.; Hudson, T.J.; Klanderman, B.J.; Freimer, N.B.; Silverman, E.K.; Celedón, J.C. Sex-specific linkage to total serum immunoglobulin E in families of children with asthma in Costa Rica. Hum. Mol. Genet. 2007, 16, 243-253.
34. Imamura, M.; Okunishi, K.; Ohtsu, H.; Nakagome, K.; Harada, H.; Tanaka, R.; Yamamoto, K.; Dohi, M. Pravastatin attenuates allergic airway inflammation by suppressing antigen sensitisation, interleukin 17 production and antigen presentation in the lung. Thorax 2009, 64, 44-49.
35. Saenz, S.A.; Siracusa, M.C.; Perrigoue, J.G.; Spencer, S.P.; Urban, J.F. Jr.; Tocker, J.E.; Budelsky, A.L.; Kleinschek, M.A.; Kastelein, R.A.; Kambayashi, T.; Bhandoola, A.; Artis, D. IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature 2010, 464, 1362-1366.
36. Gusareva, E.S.; Bragina, E.J.; Buinova, S.N.; Chernyak, B.A.; Chernyak, B.A.; Puzyrev, V.P.; Ogorodova, L.M.; Lipoldová, M. Chromosome 12q24.3 controls sensitization to cat allergen in patients with asthma from Siberia, Russia. Immunol. Lett. 2009, 125, 1-6.
37. Gudbjartsson, D.F.; Bjornsdottir, U.S.; Halapi, E.; Helgadottir, A.; Helgadottir, A.; Sulem, P.; Jonsdottir, G.M.; Thorleifsson, G.; Helgadottir, H.; Steinthorsdottir, V., et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat. Genet. 2009, 41, 342-347.
38. Celedón, J.C.; Soto-Quiros, M.E.; Avila, L.; Lake, S.L.; Liang, C.; Fournier, E.; Spesny, M.; Hersh, C.P.; Sylvia, J.S.; Hudson, T.J., et al. Significant linkage to airway responsiveness on chromosome 12q24 in families of children with asthma in Costa Rica. Hum. Genet. 2007, 120, 691-699.
39. Raby, B.A.; Silverman, E.K.; Lazarus, R.; Lange, C.; Kwiatkowski, D.J.; Weiss, S.T. Chromosome 12q harbors multiple genetic loci related to asthma and asthma-related phenotypes. Hum. Mol. Genet. 2003, 12, 1973-1979.
40. Randolph, A.G.; Lange, C.; Silverman, E.K.; Lazarus, R.; Silverman, E.S.; Raby, B.; Brown, A.; Ozonoff, A.; Richter, B.; Weiss, S.T. The IL12B gene is associated with asthma. Am. J. Hum. Genet. 2004, 75, 709-715.
41. Silverman, E.K.; Kwiatkowski, D.J.; Sylvia, J.S.; Lazarus, R.; Drazen, J.M.; Lange, C.; Laird, N.M.; Weiss, S.T. Family-based association analysis of beta2-adrenergic receptor polymorphisms in the childhood asthma management program. J. Allergy Clin. Immunol. 2003, 112, 870-876.
42. Lin, M.T.; Simon, D.K.; Ahn, C.H.; Kim, L.M.; Beal, M.F. High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. Hum. Mol. Genet. 2002, 11, 133-145.
43. Simon, D.K.; Lin, M.T.; Zheng, L.; Liu, G.J.; Liu, G.J.; Ahn, C.H.; Kim, L.M.; Mauck, W.M.; Twu, F.; Beal, M.F.; Johns, D.R. Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease. Neurobiol. Aging 2004, 25, 71-81.
44. Reeve, A.K.; Krishnan, K.J.; Turnbull, D. Mitochondrial DNA mutations in disease, aging, and neurodegeneration. Ann. NY Acad. Sci. 2008, 1147, 21-29.
45. Reddy, P.H. Mitochondrial medicine for aging and neurodegenerative diseases. Neuromol. Med. 2008, 10, 291-315.
46. Tońska, K.; Sołyga, A.; Bartnik, E. Mitochondria and aging: innocent bystanders or guilty parties? J. Appl. Genet. 2009, 50, 55-62.
47. Beal, M.F. Mitochondria take center stage in aging and neurodegeneration. Ann. Neurol. 2005, 58, 495-505.
48. Lin, M.T.; Beal, M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006, 443, 787-795.
49. Cooper, J.M.; Mann, V.M.; Schapira, A.H. Analyses of mitochondrial respiratory chain function and mitochondrial DNA deletion in human skeletal muscle: Effect of ageing. J. Neurol. Sci. 1992, 113, 91-98.
50. Corral-Debrinski, M.; Horton, T.; Lott, M.T.; Shoffner, J.M.; Beal, M.F.; Wallace, D.C. Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nat. Genet. 1992, 2, 324-329.
51. Cortopassi, G.A.; Shibata, D.; Soong, N.W.; Arnheim, N. A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. Proc. Natl. Acad. Sci. USA 1992, 89, 7370-7374.
52. Lee, H.C.; Pang, C.Y.; Hsu, H.S.; Wei, Y.H. Differential accumulations of 4,977 bp deletion in mitochondrial DNA of various tissues in human ageing. Biochim. Biophys. Acta 1994, 1226, 37-43.
53. Schwarze, S.R.; Lee, C.M.; Chung, S.S.; Roecker, E.B.; Weindruch, R.; Aiken, J.M. High levels of mitochondrial DNA deletions in skeletal muscle of old rhesus monkeys. Mech. Ageing Dev. 1995, 83, 91-101.
54. Lim, P.; Cheng, Y.; Wei, Y. Large-scale mitochondrial DNA deletions in skeletal muscle of patients with end-stage renal disease. Free Rad. Biol. Med. 2000, 29, 454-463.
55. Jessie, B.C.; Sun, C.Q.; Wallace, D.C.; Petros, J.A. Accumulation of mitochondrial DNA deletions in the malignant prostate of patients of different ages. Exp. Gerontol. 2001, 37, 169-174.
56. Hirai, K.; Aliev, G.; Nunomura, A.; Nunomura, A.; Fujioka, H.; Russell, R.L.; Atwood, C.S.; Johnson, A.B.; Kress, Y.; Vinters, H.V., et al. Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 2001, 21, 3017-3023.
57. Swerdlow, R.H. Treating neurodegeneration by modifying mitochondria: potential solutions to a "complex" problem. Antioxid. Redox Signal. 2007, 9, 1591-1603.
58. DiMauro, S.; Schon, E.A. Mitochondrial disorders in the nervous system. Annu. Rev. Neurosci. 2008, 31, 91-123.
59. Reddy, P.H. Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons. Antioxid. Redox Signal. 2007, 9, 1647-1658.
60. Reddy, P.H.; Beal, M.F. Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain Res. Brain Res. Rev. 2005, 49, 618-632.
61. Anderson, S.; Bankier, A.T.; Barrell, B.G.; de Bruijn, M.H.; Coulson, A.R.; Drouin, J.; Eperon, I.C.; Nierlich, D.P.; Roe, B.A.; Sanger, F.; Schreier, P.H.; Smith, A.J.; Staden, R.; Young, I.G. Sequence and organization of the human mitochondrial genome. Nature 1981, 290, 457-465.
62. Bucchieri, F.; Puddicombe, S.M.; Lordan, J.L.; Richter, A.; Konstantinidis, A.; Holloway, J.W.; Thornber, M.; Puddicombe, S.M.; Buchanan D.; Wilson, S.J.; Djukanović R.; Holgate. S.T.; Davies, D.E. Asthmatic bronchial epithelium is more susceptible to oxidant-induced apoptosis. Am. J. Respir. Cell Mol. Biol. 2002, 27, 179-185.
63. Truong-Tran, A.Q.; Grosser, D.; Ruffin, R.E.; Murgia, C.; Zalowski, P.D. Apoptosis in the normal and inflamed airway epithelium: role of zinc in epithelial protection and procaspase-3 regulation. Biochem. Pharmacol. 2003, 66, 1459-1468.
64. Reddy, P.H. Mitochondrial oxidative damage in aging and Alzheimer's disease: implications for mitochondrially targeted antioxidant therapeutics. J. Biomed. Biotechnol. 2006, 2006, 1-13.
65. Reddy, P.H. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease. J. Neurochem. 2006, 96, 1-13.
66. Vignola, A.M.; Scichilone, N.; Bousquet, J.; Bonsignore, G.; Bellia, V. Aging and asthma: pathophysiological mechanisms. Allergy 2003, 58, 165-175.
67. Braman, S.S. Asthma in the elderly patient. Clin. Chest Med. 1993, 14, 413-422.
68. Isoaho, R.; Puolijoki, H.; Huhti, E.; Kivelä, S.L.; Tala, E. Prevalence of asthma in elderly Finns. J. Clin. Epidemiol. 1994, 47, 1109-1118.
69. Dyer, C.A.; Hill, S.L.; Stockley, R.A.; Sinclair, A.J. Quality of life in elderly subjects with a diagnostic label of asthma from general practice registers. Eur. Respir. J. 1999, 14, 39-45.
70. Dow, L.; Fowler, L.; Phelps, L.; Waters, K.; Coggon, D.; Kinmonth, A.L.; Holgate, S.T. Prevalence of untreated asthma in a population sample of 6000 older adults in Bristol, UK. Thorax 2001, 56, 472-476.
71. Thurlbeck, W.M. Morphology of Aging Lung; Raven Press: New York, NY, USA, 1991.
72. Yung, R.L. Changes in immune function with age. Rheum. Dis. Clin. North Am. 2000, 26, 455-473.
73. Servais, S.; Boussouar, A.; Molnar, A.; Douki, T.; Pequignot, J.M.; Favier, R. Age-related sensitivity to lung oxidative stress during ozone exposure. Free Radic. Res. 2005, 39, 305-316.
74. Fahn, H.J.; Wang, L.S.; Kao, S.H.; Chang, S.C.; Huang, M.H.; Wei, Y.H. Smoking-associated mitochondrial DNA mutations and lipid peroxidation in human lung tissues. Am. J. Respir. Cell Mol. Biol. 1998, 19, 901-919.
75. Wood, L.G.; Gibson, P.G.; Garg, M.L. Biomarkers of lipid peroxidation, airway inflammation and asthma. Eur. Respir. J. 2003, 21, 177-186.
76. Hayashi, T.; Ishii, A.; Nakai, S.; Hasegawa, K. Ultrastructure of goblet-cell metaplasia from Clara cell in the allergic asthmatic airway inflammation in a mouse model of asthma in vivo. Virchows Arch 2004, 444, 66-73.
77. Konrádová, V.; Copová, C.; Suková, B.; Houstk, J. Ultrastructure of the bronchial epithelium in three children with asthma. Pediatr. Pulmonol. 1985, 1, 182-187.
78. Comhair, S.A.; Bhathena, P.R.; Dweik, R.A.; Kavuru, M.; Erzurum, S.C. Rapid loss of superoxide dismutase activity during antigen-induced asthmatic response. Lancet 2000, 355, 624.
79. Comhair, S.A.; Ricci, K.S.; Arroliga, M.; Lara, A.R.; Dweik, R.A.; Song, W.; Hazen, S.L.; Bleecker, E.R.; Busse, W.W.; Chung, K.F., et al. Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma. Am. J. Respir. Crit. Care Med. 2005, 172, 306-313
80. De Raeve, H.R.; Thunnissen, F.B.; Kaneko, F.T.; Guo, F.H.; Lewis, M.; Kavuru, M.S.; Secic, M.; Thomassen, M.J.; Erzurum, S.C. Decreased Cu, Zn-SOD activity in asthmatic airway epithelium: correction by inhaled corticosteroid in vivo. Am. J. Physiol. 1997, 272, L148-L154.
81. Wu, W.; Samoszuk, M.K.; Comhair, S.A.; Thomassen, M.J.; Thomassen, M.J.; Farver, C.F.; Dweik, R.A.; Kavuru, M.S.; Erzurum, S.C.; Hazen, S.L. Eosinophils generate brominating oxidants in allergen-induced asthma. J. Clin. Invest. 2000, 105, 1455-1463.
82. Thomassen, M.J.; Raychaudhuri, B.; Dweik, R.A.; Farver, C.; Buhrow, L.; Malur, A.; Connors, M.J.; Drazba, J.; Hammel, J.; Erzurum, S.C.; Kavuru, M.S. Nitric oxide regulation of asthmatic airway inflammation with segmental allergen challenge. J. Allergy Clin. Immunol. 1999, 104, 1174-1182.
83. Fitzpatrick, A.M.; Teague, W.G.; Holguin F, Yeh, M.; Brown, L.A. Severe asthma research program. Airway glutathione homeostasis is altered in children with severe asthma: evidence for oxidant stress. J. Allergy Clin. Immunol. 2009, 123, 146-152.
84. Comhair, S.A.; Bhathena, P.R.; Farver, C.; Thunnissen, F.B.; Erzurum, S.C. Extracellular glutathione peroxidase induction in asthmatic lungs: evidence for redox regulation of expression in human airway epithelial cells. FASEB J. 2001, 15, 70-78.
85. MacPherson, J.C.; Comhair, S.A.; Erzurum, S.C.; Klein, D.F.; Lipscomb M.F.; Kavuru, M.S.; Samoszuk, M.K.; Hazen, S.L. Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species. J. Immunol. 2001, 166, 5763-5772.
86. Takeda, K.; Gelfand, E.W. Mouse models of allergic diseases. Curr. Opin. Immunol. 2009, 21, 660-665.
87. Nials, A.T.; Uddin, S. Mouse models of allergic asthma: acute and chronic allergen challenge. Dis. Model. Mech. 2008, 1, 213-220.
88. Finkelman, F.D.; Wills-Karp, M. Usefulness and optimization of mouse models of allergic airway disease. J. Allergy Clin. Immunol. 2008, 121, 603-606.
89. Wenzel, S.; Holgate, S.T. The mouse trap: It still yields few answers in asthma. Am. J. Respir. Crit. Care Med. 2006, 174, 1173-1176; discussion 1176-1178.
90. Park, C.S.; Kim, T.B.; Lee, K.Y.; Moon, K.A.; Bae, Y.J.; Jang, M.K.; Cho, Y.S.; Moon, H.B. Increased oxidative stress in the airway and development of allergic inflammation in a mouse model of asthma. Ann. Allergy Asthma Immunol. 2009, 103, 238-247.
91. Konga, D.B.; Kim, Y.; Hong, S.C.; Roh, Y.M.; Lee, C.M.; Kim, K.Y.; Lee, S.M. Oxidative stress and antioxidant defenses in asthmatic murine model exposed to printer emissions and environmental tobacco smoke. J. Environ. Pathol. Toxicol. Oncol. 2009, 28, 325-340.
92. Bharadwaj, A.S.; Agrawal, D.K. Flt3 ligand generates morphologically distinct semimature dendritic cells in ovalbumin-sensitized mice. Mol. Pathol. 2007, 83, 17-24.
93. Zhang, L.; Wang, M.; Kang, X.; Boontheung, P.; Li, N.; Nel, A.E.; Loo, J.A. Oxidative stress and asthma: proteome analysis of chitinase-like proteins and FIZZ1 in lung tissue and bronchoalveolar lavage fluid. J. Proteome Res. 2009, 8, 1631-1638.
94. Inoue, K.; Takano, H.; Koike, E.; Warabi, E.; Yanagawa, T.; Yanagisawa, R.; Ishii, T. Peroxiredoxin I is a negative regulator of Th2-dominant allergic asthma. Int. Immunopharmacol. 2009, 9, 1281-1288.
95. Lee, K.S.; Park, H.S.; Park, S.J.; Kim, S.R.; Min, K.H.; Jin, S.M.; Li, L.; Lee, Y.C. An antioxidant modulates expression of receptor activator of NF-kappaB in asthma. Exp. Mol. Med. 2006, 38, 217-229.
96. Lee, K.S.; Kim, S.R.; Park, S.J.; Min, K.H.; Lee, H.K.; Park, H.S.; Min, K.H.; Jin, S.M.; Lee, Y.C. Antioxidant down-regulates interleukin-18 expression in asthma. Mol. Pharmacol. 2006, 70, 1184-1193.
97. Castro, S.M.; Guerrero-Plata, A.; Suarez-Real, G.; Adegboyega, P.A.; Colasurdo, G.N.; Khan, A.M.; Garofalo, R.P.; Casola, A. Antioxidant treatment ameliorates respiratory syncytial virusinduced disease and lung inflammation. Am. J. Respir. Crit. Care Med. 2006, 174, 1361-1369.
98. Mabalirajan, U.; Aich, J.; Leishangthem, G.D.; Sharma, S.K.; Dinda, A.K.; Ghosh, B. Effects of vitamin E on mitochondrial dysfunction and asthma features in an experimental allergic murine model. J. Appl. Physiol. 2009, 107, 1285-1292.
99. Mabalirajan, U.; Dinda, A.K.; Sharma, S.K.; Ghosh, B. Esculetin restores mitochondrial dysfunction and reduces allergic asthma features in experimental murine model. J. Immunol. 2009, 183, 2059-2067.
100. Lee, M.; Kim, S.; Kwon, O.K.; Oh, S.R.; Lee, H.K.; Ahn, K. Anti-inflammatory and anti-asthmatic effects of resveratrol, a polyphenolic stilbene, in a mouse model of allergic asthma. Int. Immunopharmacol. 2009, 9, 418-424.
101. Dittrich, A.M.; Meyer, H.A.; Krokowski, M.; Quarcoo, D.; Ahrens, B.; Kube, S.M.; Witzenrath, M.; Esworthy, R.S.; Chu, F.F.; Hamelmann, E. Glutathione peroxidase-2 protects from allergen-induced airway inflammation in mice. Eur. Respir. J. 2009, 35, 1148-1154.
102. Chang, H.H.; Chen, C.S.; Lin, J.Y. High dose vitamin C supplementation increases the Th1/Th2 cytokine secretion ratio, but decreases eosinophilic infiltration in bronchoalveolar lavage fluid of ovalbumin-sensitized and challenged mice. J. Agric. Food Chem. 2009, 57, 10471-10476.
103. Ahmad, T.; Mabalirajan, U.; Ghosh, B.; Agrawal, A. Altered asymmetric dimethyl arginine metabolism in allergically inflamed mouse lungs. Am. J. Respir. Cell Mol. Biol. 2010, 42, 3-8.
104. Okamoto, N.; Murata, T.; Tamai, H.; Tanaka, H.; Nagai, H.Effects of alpha tocopherol and probucol supplements on allergen-induced airway inflammation and hyperresponsiveness in a mouse model of allergic asthma. Int. Arch. Allergy Immunol. 2006, 141, 172-180.
105. Mehta, A.K.; Arora, N.; Gaur, S.N.; Singh, B.P. Choline supplementation reduces oxidative stress in mouse model of allergic airway disease. Eur. J. Clin. Invest. 2009, 39, 934-941.
106. Braskett, M.; Riedl, M.A. Novel antioxidant approaches to the treatment of upper airway inflammation. Curr. Opin. Allergy Clin. Immunol. 2010, 10, 34-41.
107. Gazdík, F.; Gvozdjáková, A.; Nádvorníková, R.; Repická, L, Repická, L.; Jahnová, E.; Kucharská, J.; Piják, M.R.; Gazdíková, K. Decreased levels of coenzyme Q(10) in patients with bronchial asthma. Allergy 2002, 57, 811-814.
108. Gazdik, F.; Gvozdjakova, A.; Horvathova, M.; Weissova, S.; Kucharska, J.; Pijak, M.R.; Gazdikova, K. Levels of coenzyme Q10 in asthmatics. Bratisl. Lek. Listy 2002, 103, 353-356.
109. Gvozdjáková, A.; Kucharská, J.; Bartkovjaková, M.; Gazdíková, K.; Gazdík, F.E. Coenzyme Q10 supplementation reduces corticosteroids dosage in patients with bronchial asthma. Biofactors 2005, 25, 235-240.
110. Domenighetti, G.; Suter, P.M.; Schaller, M.D.; Ritz, R.; Perret, C. Treatment with Nacetylcysteine during acute respiratory distress syndrome: a randomized, double-blind, placebocontrolled clinical study. J. Crit. Care 1997, 12, 177-182.
111. Konrad, F.; Schoenberg, M.H.; Wiedmann, H.; Kilian, J.; Georgieff, M. The application of n-acetylcysteine as an antioxidant and mucolytic in mechanical ventilation in intensive care patients. A prospective, randomized, placebo-controlled, double-blind study. Anaesthesist 1995, 44, 651-658.
112. Suter, P.M.; Domenighetti, G.; Schaller, M.D.; Laverrière, M.C.; Ritz, R.; Perret, C. N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study. Chest 1994, 105, 190-194.
113. Moradi, M.; Mojtahedzadeh, M.; Mandegari, A.; Soltan-Sharifi, M.S.; Najafi, A.; Khajavi, M.R.; Hajibabayee, M.; Ghahremani, M.H. et al. The role of glutathione-S-transferase polymorphisms on clinical outcome of ALI/ARDS patient treated with N-acetylcysteine. Respir. Med. 2009, 103, 434-441.
114. Devereux, G.; Turner, S.W.; Craig, L.C.; McNeill, G.; Martindale, S.; Harbour, P.J.; Helms, P.J.; Seaton, A. Low maternal vitamin E intake during pregnancy is associated with asthma in 5-year-old children. Am. J. Respir. Crit. Care Med. 2006, 174, 499-507.
115. Pearson, P.J.; Lewis, S.A.; Britton, J.; Fogarty, A. Vitamin E supplements in asthma: a parallel group randomised placebo controlled trial. Thorax 2004, 59, 652-656.
116. Romieu, I.; Sienra-Monge, J.J.; Ramírez-Aguilar, M.; Moreno-Macías, H.; Reyes-Ruiz, N.I.; Estela del Río-Navarro, B.; Hernández-Avila, M.; London, S.J. Genetic polymorphism of GSTM1 and antioxidant supplementation influence lung function in relation to ozone exposure in asthmatic children in Mexico City. Thorax 2004, 59, 8-10.
117. Shahar, E.; Hassoun, G.; Pollack, S. Effect of vitamin E supplementation on the regular treatment of seasonal allergic rhinitis. Ann. Allergy Asthma Immunol. 2004, 92, 654-658.
118. Sienra-Monge, J.J.; Ramirez-Aguilar, M.; Moreno-Macias, H.; Reyes-Ruiz, N.I.; Del Río- Navarro, B.E.; Ruiz-Navarro, M.X.; Hatch, G.; Crissman, K.; Slade, R.; Devlin, R.B.; Romieu, I. Antioxidant supplementation and nasal inflammatory responses among young asthmatics exposed to high levels of ozone. Clin. Exp. Immunol. 2004, 138, 317-322.
119. Papas, K.A.; Sontag, M.K.; Pardee, C.; Sokol, RJ.; Sagel, S.D.; Accurso, F.J.; Wagener, J.S. A pilot study on the safety and efficacy of a novel antioxidant rich formulation in patients with cystic fibrosis. J. Cyst. Fibros. 2008, 7, 60-67.
120. Szeto, H.H. Development of mitochondria-targeted aromatic-cationic peptides for neurodegenerative diseases. Ann. NY Acad. Sci. 2008; 1147, 112-121.
121. Murphy, M.P.; Smith, R.A. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu. Rev. Pharmacol. Toxicol. 2007, 47, 629-656.
122. Szeto, H.H. Cell-permeable, mitochondrial-targeted, peptide antioxidants. AAPS J. 2006, 8, E277-E283.
123. Szeto, H.H. Mitochondria-targeted peptide antioxidants: Novel neuroprotective agents. AAPS J. 2006, 8, E521-E531.
124. Petri, S.; Kiaei, M.; Damiano, M.; Hiller, A.; Wille, E.; Manfredi, G.; Calingasan, N.Y.; Szeto, H.H.; Beal, M.F. Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis. J. Neurochem. 2006, 98, 1141-1148.
125. Yang, L.; Zhao, K.; Calingasan, N.Y.; Luo, G.; Szeto, H.H.; Beal, M.F. Mitochondria targeted peptides protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. Antioxid. Redox Signal. 2009, 11, 2095-2102.
126. Reddy, T.P.; Manczak, M.; Calkins, M.J.; Mao, P.; Reddy, A.P.; Shirendeb, U.; Park, B.; Reddy, P.H. Toxicity of neurons treated with herbicides and neuroprotection by mitochondria-targeted antioxidant SS31. Int. J. Environ. Res. Public Health 2011, 8, 203-221.
127. Manczak, M.; Mao, P.; Calkins, M.J.; Cornea, A.; Reddy, A.P.; Murphy, M.P.; Szeto, H.H.; Park, B.; Reddy, P.H. Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons. J. Alzheimers Dis. 2010, 20 (Suppl. 2), S609-S631.